Both in Pharmaceuticals
Processa Pharmaceuticals vs Pulmatrix
Over the past year PCSA returned −78.7% and PULM returned −71.7%; their daily moves had a correlation of 0.01.
PCSA −78.7% PULM −71.7%Growth of $1, one year, split-adjusted
| Metric | PCSA | PULM |
|---|---|---|
| Price | $1.89 | $1.40 |
| Market cap | $5.3M | $5.1M |
| Today | 0.00% | −1.06% |
| 1 month | +16.7% | −9.1% |
| 6 months | −25.9% | +8.5% |
| Year to date | −34.4% | −37.2% |
| 1 year | −80.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $196.3K | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 63.9% |
| Short % of float | 2.0% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).